Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
AssigneeToyama Chemical Co., Ltd.
InventorsTatsuo KIMURA, Noboru IWAKAMI, Akihito SAITOH
Life of this patent
Estimating the term…
Abstract
An alkyl ether derivative represented by the following general formula [1] or its salt: wherein R1 and R2 represent each a substituent such as hydrogen, halogeno or alkyl; R3 represents alkylamino, amino or hydroxyl; the ring A represents a 5- or 6-membered aromatic heterocycle or a benzene ring; m and n are each an integer of from 1 to 6; and p is an integer of from 1 to 3; shows an effect of protecting retinal nerve cells and, therefore, is useful as a preventive and/or a remedy for retinal nerve diseases such as glaucoma, diabetic retinopathy, retinal artery obstruction, retinal venous obstruction, macular degeneration and retinopathy of prematurity.
Claims9
1-8. (canceled)
A method for treating a retinal nerve disease comprising administering to a subject in need thereof an alkyl ether derivative, wherein the alkyl ether derivative is 1-(3-(2-(1-benzothiophene-5-yl)ethoxy)propyl)-3-azetidinol or its salt.
Dependencies are inferred from the claim text.